These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17235298)

  • 1. Armed interference: oncolytic viruses engineered to carry antitumor shRNAs.
    Kirn D
    Mol Ther; 2007 Feb; 15(2):227-8. PubMed ID: 17235298
    [No Abstract]   [Full Text] [Related]  

  • 2. VEGF-specific short hairpin RNA-expressing oncolytic adenovirus elicits potent inhibition of angiogenesis and tumor growth.
    Yoo JY; Kim JH; Kwon YG; Kim EC; Kim NK; Choi HJ; Yun CO
    Mol Ther; 2007 Feb; 15(2):295-302. PubMed ID: 17235307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncolytic-adenovirus-expressed RNA interference for cancer therapy.
    Pei DS; Di JH; Chen FF; Zheng JN
    Expert Opin Biol Ther; 2010 Sep; 10(9):1331-41. PubMed ID: 20684738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of oncolytic virotherapy with armed shRNA.
    Guo W; Fang B
    Cancer Biol Ther; 2009 Jan; 8(1):92-3. PubMed ID: 19127117
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of renal cancer cell growth by oncolytic adenovirus armed short hairpin RNA targeting hTERT gene.
    Zheng JN; Pei DS; Sun FH; Zhang BF; Liu XY; Gu JF; Liu YH; Hu XL; Mao LJ; Wen RM; Liu JJ; Li W
    Cancer Biol Ther; 2009 Jan; 8(1):84-91. PubMed ID: 19029834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncolytic Immunotherapy.
    Hennessy ML; Bommareddy PK; Boland G; Kaufman HL
    Surg Oncol Clin N Am; 2019 Jul; 28(3):419-430. PubMed ID: 31079797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained local delivery of oncolytic short hairpin RNA adenoviruses for treatment of head and neck cancer.
    Jung SH; Choi JW; Yun CO; Yhee JY; Price R; Kim SH; Kwon IC; Ghandehari H
    J Gene Med; 2014; 16(5-6):143-52. PubMed ID: 24962819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy progress and prospects cancer: oncolytic viruses.
    Liu TC; Kirn D
    Gene Ther; 2008 Jun; 15(12):877-84. PubMed ID: 18418413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fighting fire with fire: rewiring tumor cells for oncolytic virotherapy.
    Mahoney DJ; Stojdl DF
    Future Oncol; 2012 Mar; 8(3):219-21. PubMed ID: 22409457
    [No Abstract]   [Full Text] [Related]  

  • 10. Biological therapy with oncolytic herpesvirus.
    Benencia F; Coukos G
    Adv Exp Med Biol; 2008; 622():221-33. PubMed ID: 18546631
    [No Abstract]   [Full Text] [Related]  

  • 11. [Construction of an oncolytic adenovirus expressing small hairpin RNA and targeting the SATB1 gene].
    Mao LJ; Zheng JN; Li W; Wang JQ; Chen JC; Sun XQ
    Zhonghua Nan Ke Xue; 2010 Aug; 16(8):679-83. PubMed ID: 21090340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advance in herpes simplex viruses for cancer therapy.
    Liu S; Dai M; You L; Zhao Y
    Sci China Life Sci; 2013 Apr; 56(4):298-305. PubMed ID: 23564184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chapter four--Design of improved oncolytic adenoviruses.
    Alemany R
    Adv Cancer Res; 2012; 115():93-114. PubMed ID: 23021243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy.
    Allan KJ; Mahoney DJ; Baird SD; Lefebvre CA; Stojdl DF
    J Vis Exp; 2018 Apr; (134):. PubMed ID: 29683442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncolytic viruses: immune or cytolytic therapy?
    Bell J
    Mol Ther; 2014 Jul; 22(7):1231-1232. PubMed ID: 24981435
    [No Abstract]   [Full Text] [Related]  

  • 16. Mounting a strategic offense: fighting tumor vasculature with oncolytic viruses.
    Angarita FA; Acuna SA; Ottolino-Perry K; Zerhouni S; McCart JA
    Trends Mol Med; 2013 Jun; 19(6):378-92. PubMed ID: 23540715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of renal cancer cell growth in vitro and in vivo with oncolytic adenovirus armed short hairpin RNA targeting Ki-67 encoding mRNA.
    Zheng JN; Pei DS; Mao LJ; Liu XY; Mei DD; Zhang BF; Shi Z; Wen RM; Sun XQ
    Cancer Gene Ther; 2009 Jan; 16(1):20-32. PubMed ID: 18690204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncolytic Viruses for Systemic Administration: Engineering a Whole Different Animal.
    Atasheva S; Shayakhmetov DM
    Mol Ther; 2021 Mar; 29(3):904-907. PubMed ID: 33577782
    [No Abstract]   [Full Text] [Related]  

  • 19. Virus combinations and chemotherapy for the treatment of human cancers.
    Kumar S; Gao L; Yeagy B; Reid T
    Curr Opin Mol Ther; 2008 Aug; 10(4):371-9. PubMed ID: 18683102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetic, immunological, and pharmacological strategies to generate improved oncolytic viruses].
    Pol J; Le Bœuf F; Diallo JS
    Med Sci (Paris); 2013 Feb; 29(2):165-73. PubMed ID: 23452603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.